Similar Items: Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis
- Evaluation of Disease Modifying Therapies and Prognostic Factors Affecting Multiple Sclerosis Progression in a Local Centre of Hong Kong
- Why do few Medicare beneficiaries switch their Part D prescription drug plans? Insights from behavioral sciences
- Medicare Advantage Civil Monetary Penalties and Profits
- Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
- Global Prevalence and Risk Factors of Suicidal Ideation in Multiple Sclerosis: A Systematic Review and Meta‐Analysis
- Physicians’ Knowledge and Practice Regarding Multiple Sclerosis (MS) in Saudi Arabia: A Cross-Sectional Study